Shanghai Chest Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1957-01-01
- Employees
- -
- Market Cap
- -
AF Ablation for HF With Reduced EF
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2023-04-24
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 96
- Registration Number
- NCT05827172
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05816499
- Locations
- 🇨🇳
lejie Cao, Hefei, Anhui, China
🇨🇳Jing Wang, Qingdao, Shandong, China
🇨🇳Shanghai Chest Hospital, Shanghai, Shanghai, China
The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 124
- Registration Number
- NCT05798845
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 54
- Registration Number
- NCT05751187
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Application of Mixed Reality Technique for Percutaneous Lung Nodule Localization: A Prospective, Randomized, Controlled Trial
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-11-21
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 74
- Registration Number
- NCT05715996
- Locations
- 🇨🇳
Zuodong Song, Shanghai, Shanghai, China
Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations
Recruiting
- Conditions
- First Posted Date
- 2023-01-27
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT05701787
- Locations
- 🇨🇳
Xiaomin Niu, Shanghai, Shanghai, China
Molecular Analysis and Treatment Options of Thymic Malignancies
Recruiting
- Conditions
- First Posted Date
- 2022-12-29
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT05667948
- Locations
- 🇨🇳
Xiaomin Niu, Shanghai, Shanghai, China
Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）
- First Posted Date
- 2022-12-14
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05650216
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2022-11-18
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05621707
Electroacupuncture Intervention in Catheter Ablation of Atrial Fibrillation
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-12
- Last Posted Date
- 2022-10-12
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05575544
© Copyright 2024. All Rights Reserved by MedPath